CAS 1033040-23-1

Fórmula: C25H22N8O2

InChI: InChI=1S/C25H22N8O2/c1-14-10-11-19(12-15(14)2)33-25(35)22(16(3)30-33)27-26-21-9-5-8-20(23(21)34)17-6-4-7-18(13-17)24-28-31-32-29-24/h4-13,30,34H,1-3H3,(H,28,29,31,32)

Clave InChI: YLSNQYHZCMCURB-UHFFFAOYSA-N

SMILES: CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)N=NC3=CC=CC(=C3O)C4=CC(=CC=C4)C5=NNN=N5)C

TPO agonist 1

CAS: 1033040-23-1

TPO agonist 1

Fórmula: C₂₅H₂₂N₈O₂

Pureza: ≥95%

Peso molecular: 466.49

Ref: 54-OR1114935

TPO agonist 1

CAS: 1033040-23-1

Pureza: 98.0%

Ref: IN-DA008TPN

TPO agonist 1

CAS: 1033040-23-1

TPO agonist 1 is a molecule that has been shown to have clinical use in the treatment of thrombocytopenia. It is also used in the treatment of hepatitis and neonatal thrombocytopenia. TPO agonist 1 is a growth factor that stimulates the production of platelets and increases blood clotting. The most common side effects are nausea, vomiting, and diarrhea. TPO agonist 1 can be taken orally with or without food.

Fórmula: C₂₅H₂₂N₈O₂

Pureza: Min. 95%

Peso molecular: 466.49 g/mol

Ref: 3D-IRB04023

TPO agonist 1

CAS: 1033040-23-1

TPO agonist 1, Thrombopoietin (TPO) mimetic, promotes platelet/megakaryocyte production, for thrombocytopenia research.

Fórmula: C₂₅H₂₂N₈O₂

Pureza: 98%

Forma y color: Red Solid

Peso molecular: 466.4946

Ref: TM-T17146